0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-605.22%PremiumMay 16, 2025Expiry Date4.29Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.13Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ironwood Pharmaceuticals Stock Discussion
$Cellectar BioSciences (CLRB.US)$
$Gossamer Bio (GOSS.US)$
Ironwood's Apraglutide Faces FDA Setback: Strategic Review Launched After Trial Issues
Ironwood Pharmaceuticals Initiates Apraglutide Nda Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
No comment yet